 Gamma globulin prophylaxis post-transfusion non-A non-B hepatitis cardiac surgery cardiopulmonary bypass prospective randomized study immune serum globulin ISG prevention post-transfusion hepatitis patients controls gammaglobulin placebo ISG valve replacement coronary artery bypass extracorporeal circulation dose ISG ml i.m premedication ml i.m postoperative day Probable non-A non-B hepatitis ten controls ISG group ISG patients controls non-A non-B hepatitis serum aminotransferase values years biopsy hepatitis mild control ISG patients Low-dose gamma globulin incidence acute probable non-A non-B hepatitis cardiac surgery cardiopulmonary bypass